ALS patients genetic characterization ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 1 |
2. 筋萎縮性側索硬化症
臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03073239 (ClinicalTrials.gov) | December 2016 | 26/3/2016 | Amyotrophic Lateral Sclerosis: a New Paradigm | Amyotrophic Lateral Sclerosis: a New Paradigm | Amyotrophic Lateral Sclerosis | Genetic: ALS patients genetic characterization;Other: ALS patients epidemiological caracterization | Conde, Bebiana, M.D. | NULL | Completed | 18 Years | N/A | All | 30 | Portugal |